Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Envista Holdings Corp
NVST
NYSE·Healthcare·Medical - Equipment & Services·Mkt cap $4.4B
$27.46
▲ +1.05%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$18.77 - $30.42
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 34.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive product portfolio across implants, orthodontics, and equipment reduces customer switching costs
- Proprietary digital software and imaging technology creates recurring revenue and customer lock-in
- Established distribution network and strong relationships with dental professionals globally
- Significant scale and manufacturing expertise in specialized dental products
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising global demand for dental procedures due to aging populations and increased healthcare awareness
Value
Fairly valued vs sector peers
Momentum
Strong
+5.3% over 3m
Quality
Strong
Exceptional business - top-tier fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying NVST right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 30, 2026
MAY 6, 2026
Reported EPS of $0.36 vs $0.31 consensus (+16.1% surprise). Revenue of $705.5M vs $680.0M expected (+3.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+16.1%
Next: Jul 30, 2026
Revenue trend · last 8Q
—
—
—
—
+8%
+11%
+15%
+14%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$633.1M
$601.0M
$652.9M
$616.9M
$682.1M
$669.9M
$750.6M
$705.5M
Margins · last 8Q
Gross
55.3%
Operating
8.9%
Profit
5.5%
Wall Street consensus
10 analysts · 40% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
40%
Hold
60%
Sell
0%
Median Price Target
$31.00
▲ +12.9% vs $27.46
Latest: JP Morgan · May 7, 2026
2 analysts covering
vs Industry
How NVST stacks vs Medical - Equipment & Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.